ssential hypertension is associated with increased peripheral vascular resistance to blood flow. 1 Resistance arteries are vessels with lumen diameters measuring Ͻ400 m when relaxed, and they constitute the major site of generation of vascular resistance. 2 These vessels include small arteries, with relaxed passive lumens of more than Ϸ100 m (values vary between authors), and arterioles, which are smaller. A significant role has been proposed for small arteries in the pathogenesis of hypertension 3 and its outcomes. 4 The fundamental cause of increased peripheral resistance is a decrease in lumen diameter. According to Poiseuille's law, resistance varies inversely with the fourth power of the blood vessel radius, so that a small decrease in the lumen markedly increases resistance.
In hypertension, the vascular changes that produce this decreased lumen size may be structural, mechanical, and functional. Recent evidence that adhesion molecules like integrins and extracellular matrix components are involved in modulating the resistance vasculature in hypertension is discussed. We will not examine the important question of whether the resistance-artery phenotype is a primary abnormality or a consequence of hemodynamic or endocrine, paracrine, or autocrine trophic factors present or activated by blood pressure elevation. Whether the structural, molecular, cellular, and functional vascular changes result from a genetically programmed abnormality in some forms of hypertension has not yet been elucidated.
Structural Abnormalities of Resistance Arteries in Hypertension Description
In hypertension, the change in structure of resistance arteries involves a combination of 2 processes, 1 termed eutrophic remodeling and the other, hypertrophic remodeling ( Figure  1 ). 5 In eutrophic remodeling, the outer diameter and the lumen are decreased and the cross-sectional area of the media is unaltered, resulting in a greater media-lumen ratio. 6 This type of remodeling predominates in resistance arteries from models in which the renin-angiotensin system may be playing an important role: spontaneously hypertensive rats (SHR) 7-9 and 2-kidney 1 clip Goldblatt hypertensive rats. 10 In hypertensive humans, eutrophic remodeling is found in mild, essential hypertensive patients. [11] [12] [13] [14] In contrast, hypertrophic remodeling involves a thickening of the media that encroaches on the lumen. The narrowed lumen is thus associated with an increased media-lumen ratio and medial cross-sectional area. Hypertrophic remodeling predominates in rat models of severe hypertension in which the endothelin system is activated, such as deoxycorticosterone (DOCA)-salt hypertensive rats, 15 1-kidney 1 clip Goldblatt hypertensive rats, 16, 17 and Dahl salt-sensitive hypertension. 18 In humans, it can be found in renovascular hypertension and pheochromocytoma. 19 Both classes of remodeling are often present to varying degrees, and "remodeling" and "growth" indices 6, 20 are used to approximate the relative contribution of eutrophic and hypertrophic remodeling. One consideration that has received attention, mainly in experimental animal studies but less so in studies of human gluteal subcutaneous arteries, is the branching order of vessels. Arteries of the same branching order should be studied if comparisons between them are to be valid. Large arterioles (lumen diameter Ͻ100 m) likewise undergo vascular bed-specific remodeling, as reported in stroke-prone SHR. 6 In smaller arterioles, an alternate abnormality may increase vascular resistance, namely rarefaction, in which temporary (functional) or permanent (anatomic) reduction of arteriolar density has been reported in several rat models of hypertension, including Dahl salt-sensitive rats, 21 2-kidney 1 clip rats, 22 1-kidney 1 clip hypertensive rats, 23 DOCA-salt hypertensive rats, 24 and SHR. 25 
Role of Adhesion Molecules and Extracellular Matrix

Eutrophic Remodeling
In arteries that have undergone eutrophic remodeling, the vascular wall has been restructured, so that smooth muscle cells are aligned more closely and encircle the lumen more tightly without a change in the volume of the media. Eutrophic remodeling is identified experimentally as a reduction of passive lumen and outer diameters of relaxed vessels in the absence of changes in medial cross-sectional area or vascular stiffness. Several hypotheses have been proposed to explain these changes. Maintenance of media volume may involve a combination of growth and apoptotic processes, whereby programmed cell death localized to the outer periphery of the vessel may result in a reduction of the outer diameter of the vessel, whereas inward cell growth decreases lumen diameter. Apoptosis has been reported in various models of hypertension, including aortas of DOCA-salt hypertensive rats 26 and angiotensin-induced hypertensive rats. 27 However, in mesenteric arteries 28 and intramyocardial small arteries 29 from SHR, a reduction in apoptosis has also been reported.
We have also proposed that owing to changes in extracellular matrix components and corresponding adhesion receptors, interactions between smooth muscle cells and matrix proteins shift quantitatively, topographically, or both, resulting in a rearrangement of smooth muscle cells and a restructured vascular wall (Figure 2 ). 30 We recently reported that in SHR, the expression of adhesion molecules, specifically integrins, is abnormal. Integrins act as physical "joints" between extracellular matrix and cytoskeletal components and as signal-transducing receptors. On the basis of the import of their actions, we hypothesized that vascular remodeling may involve changes in these anchorage sites. Indeed, with aging from 6 to 20 weeks, mesenteric arteries from SHR exhibited an increase in expression of ␣ v ␤ 3 and ␣ 5 ␤ 1 integrins, and in adult SHR arteries, the volume density of collagen was also markedly increased. 30 Bézie et al 31 also reported an increase in ␣ 5 integrins and their main ligand, fibronectin, in SHR aortas. Such changes may represent an increase in cell-matrix attachment sites and their topographic localization (clustering?) that may modulate arterial structure (Figure 2 ).
Hypertrophic Remodeling
Growth of the media of a blood vessel results in encroachment on its lumen and may involve increased smooth muscle cell number, 32,33 size, 16 or both (although these have not been detected consistently 34 ), as well as augmented deposition of extracellular proteins. Smooth muscle cell growth may be facilitated by several extracellular matrix proteins. One putative key player in hypertension-related vascular remodeling is tenascin-C, an extracellular matrix glycoprotein that reportedly modulates vascular smooth muscle cell proliferation. Tenascin-C colocalizes with proliferating smooth muscle cells in SHR 35 and human hypertensive pulmonary arteries. 36 Moreover, interactions between ␣ v ␤ 3 integrins and tenascin-C promote epidermal growth factor-dependent growth and survival of rat pulmonary artery smooth muscle cells ( Figure  2 ). 37 Thus, tenascin-C or other ligands for ␣ v ␤ 3 integrins possibly protect smooth muscle cells from apoptosis and promote proliferation. Fibronectin matrix assembly may likewise facilitate vascular smooth muscle cell growth. As mentioned previously, total fibronectin 31 and ␣ 5 ␤ 1 integrins 30, 31 are increased in arteries of SHR. This observation suggests that fibronectin matrix assembly, which requires interaction between the arginine-glycine-aspartate (RGD) site of fibronectin and ␣ 5 ␤ 1 integrins, 38 is also elevated in SHR vessels. Moreover, disruption of fibronectin matrix assembly inhibits vascular smooth muscle cell growth, 39 underlining its potential importance in hypertrophic remodeling. Another RGD-containing protein that may be associated with proliferation is osteopontin, a secreted glycoprotein that is adhesive for vascular smooth muscle cells via ␣ v ␤ 3 integrins. 40 In vitro studies have demonstrated that osteopontin overexpression is associated with arterial smooth muscle cell proliferation 41 and may be involved in determining the synthetic/proliferative 42 phenotype of these cells previously described in hypertension.
The synthetic phenotype of vascular smooth muscle cells that predominates in hypertension 43, 44 predisposes these vessels to augmented extracellular matrix deposition, a second component of hypertrophic remodeling. Increases in the volume density of collagen occur in mesenteric resistance arteries of hypertensive rats 30, 45 and in subcutaneous resistance arteries of patients with mild essential hypertension. 46 This change may be stimulated by humoral factors whose levels or actions are enhanced in hypertension, eg, by angiotensin II. 47 In the normal artery, fibrillar collagens (types I and III) are the major constituents of the intima, media, and adventitia, whereas types IV and V collagens are situated in the endothelial and smooth muscle cell basement membranes, 48 along with collagen types I and III. 49 Proteoglycans, nonfibrillar matrix components that carry glycosaminoglycans, are synthesized by vascular smooth muscle cells in response to growth factors. 50 They may function as modulators of cell proliferation and differentiation. 51 Synthesis of proteoglycans was greater in 10-and 28-week-old SHR carotid arteries 52 and has also been found in smooth muscle cells from mesenteric resistance arteries in response to angiotensin II in SHR compared with Wistar rats. 53 The hypertension-related accumulation of extracellular matrix proteins in resistance arteries may be facilitated by diminished matrix metalloproteinase (MMP) activity. MMPs are Zn 2ϩ -and Ca 2ϩ -dependent proteolytic enzymes that degrade extracellular matrix proteins. 54 -56 -9] ) that digest denatured collagen (gelatin) as well as types IV and V collagen found in the subendothelial basement membrane; and stromelysins (eg, MMP-3) that digest adhesive molecules like laminin, fibronectin, nonfibrillar collagens, 57 and proteoglycans. 58 In sera from SHR with extensive myocardial fibrosis 59, 60 and in humans with essential hypertension, 61 enhanced synthesis of type I collagen is not balanced by an increase in type I collagen degradation. In fact, serum concentrations of MMP-1 were diminished in hypertensive patients in whom type I collagen was augmented. 62 In the aortas and mesenteric arteries of stroke-prone SHR, gene expression of types I, III, and IV collagen is upregulated. 63 In the mesenteric arterial bed, MMP-1 activity was decreased in young SHR before hypertension was established. By resulting in collagen accumulation, this process may contribute to resistance-artery hypertrophy. 64 MMP-3 activity was also decreased, 64 which may promote accumulation of fibronectin and proteoglycans in SHR. 51, 53 Pro-MMP-2 and activated MMP-2 activities were diminished in mesenteric arteries from adult SHR, 64 which could facilitate accumulation of types IV and V collagen and fibronectin. 57 By modulating the extracellular matrix profile and its interactions with adhesive receptors, diminished MMP activity may contribute to remodeling of resistance arteries in hypertension.
Mechanical Abnormalities of Resistance Arteries in Hypertension Description
The stiffness of the wall of arteries is altered in some rat models of hypertension and in essential hypertensive patients and, by influencing lumen diameter, may affect peripheral resistance to blood flow. Distensibility and compliance measure the ability of a vessel to buffer changes in pressure. Both of these measures depend on the stiffness of wall components and the geometry of the vessel and intraluminal pressure to which it is exposed. For this reason, it is important to compare vessels under isobaric conditions. Another important consideration is the level of the vasculature, branching order, or size of the vessel lumen. There may be considerable heterogeneity in distensibility with respect to vessel size. Whereas secondorder cerebral small arteries from stroke-prone SHR exhibit decreased distensibility, accounting for their apparent reduction in external diameter, third-order small arteries of Ͻ200 m exhibit remodeling with normal wall mechanics. 65 There may be other examples of this type of heterogeneity. The slope of incremental elastic modulus plotted versus vascular wall stress is a geometry-independent measure of the stiffness of wall components, which include connective tissue, smooth muscle cells, endothelial cells, and more important, collagen and elastin (less and more distensible components, respectively). In genetic and experimental rat models of salt-sensitive hypertension such as Dahl saltsensitive rats 66 and DOCA-salt rats, 67 respectively, mesenteric resistance-artery stiffness was normal compared with that in normotensive controls. However, in SHR the stiffness of mesenteric small arteries may be reduced initially. 68 This feature is followed by increases in the stiffness of wall components, with reduced compliance and distensibility in association with increased collagen deposition. 30 In 2-kidney 1 clip renal hypertensive rats 1 and 5 weeks after renal artery clipping, carotid arteries had normal mechanics under isobaric conditions, whereas after 9 and 24 weeks, they had become stiffer. 69 As already mentioned, second-order cerebral small arteries from stroke-prone SHR exhibit increased stiffness, whereas smaller third-order arteries in the same vascular bed have decreased stiffness. 65 In humans, progressive arterial stiffening and decreased vascular compliance under isobaric conditions occur as individuals age or develop hypertension. 70 However, independent of the presence of arterial hypertrophy, increased elasticity has been shown in the aorta 71 but not in the radial artery. 72 Elastic modulus was not increased in subcutaneous small arteries from hypertensive patients when these vessels were studied by the wiremyograph technique. 73 We have found slightly decreased stiffness of wall components in resistance arteries obtained from mildly hypertensive patients that were studied isobarically. 46 Subsequently, we found in other groups of subjects no difference in the incremental elastic modulus versus stress of subcutaneous resistance arteries between normotensive subjects and age-matched hypertensive patients, 74 consistent with the results of Thybo et al. 73 In the remodeled small artery in hypertension, with more closely aligned cellular and fibrillar components due to changes in adhesion of cellular and fibrillar structures, early in the disease collagen fibers may be recruited at higher distending pressures in small arteries from mildly hypertensive patients than in vessels from normotensives, whereas later, compliance of resistance arteries in hypertensives may be reduced, in part owing to the smaller lumen, greater collagen-elastin ratio, and the engagement of collagen fibers and resulting tensing of the collagen jacket at earlier portions of the pressure curve. The potential influence of perivascular collagen on vascular stiffness has not been evaluated.
Role of Adhesion Molecules and Extracellular Matrix
The earliest reports of changes in the mechanics of resistance arteries that were not the expected increased stiffness were the observations of decreased wall stiffness in cerebral arterioles from stroke-prone SHR, 65, 75 an abnormality attributed to increased elastin content. 76 In contrast, in peripheral resistance arteries, namely mesenteric, vessel wall stiffness was increased in SHR 30 and was associated with an increased volume density of collagen, an increased collagen-elastin ratio, or both. 30, 45 An important but confounding finding was that vascular stiffness was decreased in subcutaneous resistance arteries from patients with mild essential hypertension, despite an increased collagen-elastin ratio. 46 Although collagen is increased in hypertensive resistance arteries, the subtypes of collagen present in the vascular wall may be important determinants of stiffness. Conduit-artery stiffness in genetically hypertensive rats is influenced not only by hypertension per se but also by differences in the contents of collagen subtypes. 77 Aortas of 6-and 20-week-old SHR were stiffer than in age-matched Wistar-Kyoto rats, in association with a 2-fold increase of type V collagen, 78 fibronectin, or both, 31 consistent with the finding that MMP-2, which degrades primarily types IV and V collagen and fibronectin, 57 and MMP-3 activity are diminished in adult SHR mesenteric arteries. 64 Fibronectin gene expression was not increased. 31 Extracellular constituents other than collagen and elastin, such as proteoglycans, may modulate vascular stiffness. These molecules are nonfibrillar matrix components present in resistance artery smooth muscle cells from SHR 50 and are enhanced in their carotid arteries. 53 Removal of 65% of chondroitin-dermatan sulfate-containing glycosaminoglycans from mesenteric resistance arteries increased their stiffness. 79 In human resistance arteries from mild essential hypertensives, in whom vascular stiffness is initially paradoxically decreased despite increased collagen-elastin ratios, 46 there may be an increase in proteoglycans. Finally, abnormal interactions between extracellular matrix proteins, smooth muscle cells, and adhesion receptors may be the most important element by which stiffness is modulated via changes in cell attachment to fibrillar components of the extracellular matrix.
Functional Abnormalities of Resistance Arteries in Hypertension Description
Abnormal resistance-artery function in hypertension may increase peripheral resistance by reducing lumen diameter, owing to enhanced constriction. Early in experimental hypertension, increased responsiveness to norepinephrine and enhanced myogenic tone have been reported. 80 -82 Impaired endothelium-dependent relaxation may also contribute, and indeed, reductions in acetylcholine-induced and flowmediated vasodilatation in rat and human resistance arteries have been extensively documented. [83] [84] [85] Enhanced vasoconstriction is often cited as a mechanism for increased vascular tone in hypertension and has been reported in human vessels 80 and in experimental hypertension. 86 However, for the most part, hormones such as endothelin-1 and vasopressin as well as norepinephrine elicit normal or diminished constrictor responses, [87] [88] [89] suggesting that augmented vasoconstriction in hypertension may largely be due to the amplifying effect of structural or mechanical reduction of lumen diameter, according to the law of Laplace. 90, 91 There is nonetheless evidence that argues against this hypothesis. 92 This has triggered a spirited debate between groups of investigators who do not believe that structurally based enhancement of vasoconstriction occurs in hypertension 93 and those who do. 94 Augmented vasoconstriction has also been reported in response to angiotensin II, 95 the mechanism of which is not completely understood. This may be due to postreceptor signaling changes, either in the coupling of the receptor by G proteins or other events in the signaling cascade, leading to enhanced calcium release and entry into the smooth muscle cells that have been reported in vascular smooth muscle in experimental and human hypertension. 96 -99 
Role of Adhesion Molecules and Extracellular Matrix
Extracellular matrix components may also contribute to abnormal function of resistance arteries in hypertension ( Figure 2 ). Peptides carrying the minimal integrin-binding sequence RGD have induced rapid, endothelium-dependent and slower, endothelium-independent relaxation of rat aortic rings. 100 Synthetic RGD peptides or proteolyzed RGDcontaining fragments of collagen I have induced relaxation of rat skeletal muscle arterioles via binding to ␣ v ␤ 3 integrins. 101 Ligand binding to ␣ v ␤ 3 integrins with RGD peptides, vitronectin, or fibronectin may relax vessels by reducing intracellular calcium levels in vascular smooth muscle cells, 102 possibly by modifying activation of K ϩ channels 103 and L-type Ca 2ϩ -channels ( Figure 2 ). 104 Because ␣ v ␤ 3 integrins are more abundant in arteries from adult SHR, 30 ␣ v ␤ 3 -mediated relaxation should be enhanced. However, in hypertension, ␣ v ␤ 3 integrins may be occupied, unavailable for ligand binding, and therefore unable to mediate a relaxatory effect.
RGD peptides also interact with integrins to cause vascular constriction. In rat skeletal muscle arterioles, selective stimulation of abluminal but not luminal ␣ 5 ␤ 1 integrins with GRGDNP (where N indicates asparagine and P, proline) have produced arteriolar constriction that was endothelium dependent and mediated by endothelin. 105 Afferent arteriolar constriction occurred in response to GRGDSP (where S indicates serine) in the presence of N G -nitro-L-arginine methyl ester, with a concomitant increase in intracellular calcium concentration. 106 Binding to ␣ 5 ␤ 1 integrins increased L-type Ca 2ϩ currents in skeletal arteriolar smooth muscle cells. 104 In cultured pulmonary vascular smooth muscle cells in which changes in cytoskeletal stiffness paralleled cell contraction and relaxation in response to endothelin-1, cytoskeletal contractile tone increased in direct proportion to the increasing density of fibronectin coating. 107 This finding suggests that in hypertensive arteries, where fibronectin 31 and, with age, ␣ 5 ␤ 1 integrins, 30 are increased, ␣ 5 ␤ 1 integrin occupancy may contribute to increased contractility and vascular resistance.
Other extracellular matrix molecules may influence vascular function. Inhibition of vascular MMP-2 in rat mesenteric arteries reduced the vasoconstrictor effects of big endothelin-1. MMP-2 cleaves big endothelin-1 to release endothelin-1, 1-32 a new vasoconstrictor peptide. 108 
Conclusions
Abnormalities of endothelial or smooth muscle cells, adhesion molecules, and extracellular matrix in the vasculature may contribute to structural, mechanical, or functional changes that reduce the lumen size of small arteries and arterioles, thereby increasing vascular resistance in hypertension. Understanding these vascular alterations and the mechanisms whereby they are generated may offer important insights that may help in the development of therapies contributing to the prevention of vasculature-initiated endorgan damage in cardiovascular disease.
